Assessing the impact of complications on the costs of Type II diabetes
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
A desktop guide to Type 2 diabetes mellitus
European Diabetes Policy Group, 1. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00166.x · Cited by 670
Revealing the cost of Type II diabetes in Europe
Jönsson, B. (2002) · Diabetologia · doi:10.1007/s00125-002-0858-x · Cited by 392
The Progressive Cost of Complications in Type 2 Diabetes Mellitus
Brown, J. B., Pedula, K. L., & Bakst, A. W. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.16.1873 · Cited by 217
Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (2000) · Diabetologia · doi:10.1007/s001250050023 · Cited by 193
The Economic Costs of Non—Insulin-Dependent Diabetes Mellitus
Huse, D. M. (1989) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1989.03430190092037 · Cited by 190
Diabetes mortality: New light on an underestimated public health problem
Fuller, J. H., Elford, J., Goldblatt, P., & Adelstein, A. M. (1983) · Diabetologia · doi:10.1007/bf00251820 · Cited by 189
Reaven, G. M., Hollenbeck, C. B., & Chen, Y.-D. I. (1989) · Diabetologia · doi:10.1007/bf00265404 · Cited by 182
Coping with Type II diabetes: the patient’s perspective
Koopmanschap, M. (2002) · Diabetologia · doi:10.1007/s00125-002-0861-2 · Cited by 158
Direct Medical Costs of Complications Resulting From Type 2 Diabetes in Hie U.S.
O'Brien, J. A., Shomphe, L. A., Kavanagh, P. L., Raggio, G., & Caro, J. J. (1998) · Diabetes Care · doi:10.2337/diacare.21.7.1122 · Cited by 151
Research works printed but not linked: 4
- Cowie CC, Eberhardt MS (eds) (1996) Diabetes 1996: Vital Statistics. American Diabetes Association, Alexandria
- American Diabetes Association (1997) Diabetes Facts and Figures. American Diabetes Association, Alexandria
- Ward JD (1995b) The cost of diabetic foot problems. Pharmacoeconomics 8:55–57 · doi:10.2165/00019053-199500081-00012
- Smith TL, Melfi CA, Kesterson JA, Sandmann BJ, Kotsanos JG (1999) Direct medical charges associated with myocardial infarction in patients with and without diabetes. Med Care 37:AS4–AS11
Cited by
Authors/Task Force Members, Ryden, L., Standl, E., Bartnik, M., Van den Berghe, G., Betteridge, J., de Boer, M.-J., Cosentino, F., Jonsson, B., Laakso, M., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl260 · Cited by 1,647
Williams, R., Karuranga, S., Malanda, B., Saeedi, P., Basit, A., Besançon, S., Bommer, C., Esteghamati, A., Ogurtsova, K., Zhang, P., et al. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108072 · Cited by 861
Self-citationClarke, P. M., Gray, A. M., Briggs, A., Farmer, A. J., Fenn, P., Stevens, R. J., Matthews, D. R., Stratton, I. M., Holman, R. R., & on behalf of the UK Prospective Diabetes Study (UKPDS) Group (2004) · Diabetologia · doi:10.1007/s00125-004-1527-z · Cited by 615
“In particular, peripheral neuropathy and ulceration may give rise to significant reduction in quality of life, to hospitalisation and to high treatment costs [33].”
BackgroundNeuropathic Diabetic Foot Ulcers
Boulton, A. J. M., Kirsner, R. S., & Vileikyte, L. (2004) · New England Journal of Medicine · doi:10.1056/nejmcp032966 · Cited by 592
Huynh, K., Bernardo, B. C., McMullen, J. R., & Ritchie, R. H. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.01.003 · Cited by 553
Natural Products for the Treatment of Type 2 Diabetes Mellitus
Ríos, J., Francini, F., & Schinella, G. (2015) · Planta Medica · doi:10.1055/s-0035-1546131 · Cited by 446
Sinclair, A., Morley, J. E., Rodriguez-Mañas, L., Paolisso, G., Bayer, T., Zeyfang, A., Bourdel-Marchasson, I., Vischer, U., Woo, J., Chapman, I., et al. (2012) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2012.04.012 · Cited by 422
Revealing the cost of Type II diabetes in Europe
Jönsson, B. (2002) · Diabetologia · doi:10.1007/s00125-002-0858-x · Cited by 392
Quality of Care of People With Type 2 Diabetes in Eight European Countries
Stone, M. A., Charpentier, G., Doggen, K., Kuss, O., Lindblad, U., Kellner, C., Nolan, J., Pazderska, A., Rutten, G., Trento, M., et al. (2013) · Diabetes Care · doi:10.2337/dc12-1759 · Cited by 257
Coping with Type II diabetes: the patient’s perspective
Koopmanschap, M. (2002) · Diabetologia · doi:10.1007/s00125-002-0861-2 · Cited by 158
Sönnichsen, A. C., Winkler, H., Flamm, M., Panisch, S., Kowatsch, P., Klima, G., Fürthauer, B., & Weitgasser, R. (2010) · BMC Family Practice · doi:10.1186/1471-2296-11-86 · Cited by 141
“The prevalence of late diabetic complications corresponds to the European average as depicted in the CODE-2-study [4].”
Adverse Effects of Depression on Glycemic Control and Health Outcomes in People with Diabetes
Pouwer, F., Nefs, G., & Nouwen, A. (2013) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.05.002 · Cited by 132
Nikbakht, E., Khalesi, S., Singh, I., Williams, L. T., West, N. P., & Colson, N. (2018) · European Journal of Nutrition · doi:10.1007/s00394-016-1300-3 · Cited by 126
Ravaut, M., Sadeghi, H., Leung, K. K., Volkovs, M., Kornas, K., Harish, V., Watson, T., Lewis, G. F., Weisman, A., Poutanen, T., et al. (2021) · npj Digital Medicine · doi:10.1038/s41746-021-00394-8 · Cited by 121
Dijkstra, R. F., Niessen, L. W., Braspenning, J. C. C., Adang, E., & Grol, R. T. P. M. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01751.x · Cited by 81
Manickam, R., Tur, J., Badole, S. L., Chapalamadugu, K. C., Sinha, P., Wang, Z., Russ, D. W., Brotto, M., & Tipparaju, S. M. (2022) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12887 · Cited by 50
Gallwitz, B. (2013) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018813486165 · Cited by 20
Tamba, S. M., Ewane, M. E., Bonny, A., Muisi, C. N., Nana, E., Ellon, A., Mvogo, C. E., & Mandengue, S. H. (2013) · Pan African Medical Journal · doi:10.11604/pamj.2013.15.141.2104 · Cited by 18
Metadata
- Authors
- Williams, R., Van Gaal, L., & Lucioni, C.
- Venue
- Diabetologia
- Published
- 2002-06-12
- Volume
- 45
- Issue
- S1
- Pages
- S13-S17
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2035398107
- Cited by
- 353
- References
- 21
- FWCI
- 23.93
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.springer.com/tdm (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.